Amlan to Report on In-Feed Antibiotic Alternatives at Asia Pacific Poultry Conference
March 22 2018 - 9:52PM
Amlan International, a leader in the supply of innovative solutions
to improve intestinal health and productivity for livestock,
announces that Dr. Hyun Soon Lillehoj, a senior research
immunologist at the United States Department of Agriculture (USDA),
will present on alternatives to in-feed antibiotics at the Asia
Pacific Poultry Conference (APPC) in Bangkok, being held March
25–27, 2018.
Dr. Lillehoj is recognized worldwide as a leading authority on
the research and development of antibiotic alternatives for the
prevention and treatment of poultry diseases. She is the recipient
of numerous awards for excellence in research in poultry diseases
and health that span her entire career. She will make her
presentation, titled “Immune Modulation of Host Response to
Coccidiosis and Necrotic Enteritis to Reduce Antibiotics,” on
Tuesday, March 27, 2018, in the Crystal A Room, The Athenee Hotel,
Bangkok.
“Restrictions on the use of antibiotic growth promoters remain
one of the biggest challenges for poultry producers,” says Ron
Cravens, president, Amlan International, a Nevada corporation.
“We’re delighted to bring Dr. Lillehoj’s expertise to the APPC and,
along with our depth of experience in innovative intestinal health
additives, provide a productive dialogue on viable approaches to
protecting animals from biotoxic challenges to enhance livestock
health and performance.”
For more information about Amlan’s portfolio of intestinal
health products, visit Amlan.com. Note to media: For an interview
with Dr. Lillehoj, please contact Reagan Culbertson at 312.706.3256
(United States), or reagan.culbertson@amlan.com.
About Amlan InternationalOil-Dri Corporation of
America (NYSE:ODC), a Delaware corporation doing business as “Amlan
International,” has grown its product offering across the
intestinal health and AGP-alternative market, driven largely by the
research conducted at its laboratory campus in Vernon Hills,
Illinois. In 2017, the company added the Richard M. Jaffee
Laboratory for Applied Microbiology to the campus.
Amlan International sells animal health products outside of the
United States, and product availability may vary by country.
Product-associated claims do not constitute medical claims and may
differ based on government requirements. The information contained
herein is based on Amlan’s research and you should conduct your own
tests to determine the suitability of Amlan’s products for your
specific purposes. “Amlan,” “Varium” and “NeoPrime” are trademarks
of Oil-Dri Corporation of America.
Reagan B. CulbertsonMedia
Contactpress@amlan.com
Oil Dri Corp of America (NYSE:ODC)
Historical Stock Chart
From Apr 2024 to May 2024
Oil Dri Corp of America (NYSE:ODC)
Historical Stock Chart
From May 2023 to May 2024